Head

Raven Capital Management Names Dimitri Cohen Chief Investment Officer of Raven Credit

Retrieved on: 
Thursday, April 4, 2024
Green, Credit, Growth, Investment, Head

LOS ANGELES, April 04, 2024 (GLOBE NEWSWIRE) -- Raven Capital Management (“Raven”) today announced that Josh Green, President, CEO and Founder of Raven, has appointed Dimitri Cohen to the position of Chief Investment Officer of Raven Credit, effective April 2nd, 2024.

Key Points: 
  • LOS ANGELES, April 04, 2024 (GLOBE NEWSWIRE) -- Raven Capital Management (“Raven”) today announced that Josh Green, President, CEO and Founder of Raven, has appointed Dimitri Cohen to the position of Chief Investment Officer of Raven Credit, effective April 2nd, 2024.
  • Cohen, a principal at Raven since 2019, has helped to scale Raven’s private credit platform, having invested more than $2.5 billion, capitalizing on rapidly growing demand in recent years.
  • Raven, founded in 2008, is a diversified alternative investment management firm specializing in private credit.
  • “The current private credit landscape offers unparalleled opportunities, especially for non-sponsored direct lending deals,” explained Cohen.

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

Retrieved on: 
Wednesday, April 3, 2024
Growth, Goldman Sachs, Customer, Mathematical sciences, Harvard Business School, Head, Mathematics, MSIM, Corporate development

WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development. Mr. Shah, a Wall Street veteran with over 25 years of experience across key financial services industry verticals, brings broad leadership capabilities to Tevogen Bio.

Key Points: 
  • WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN ), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development.
  • Mr. Shah, a Wall Street veteran with over 25 years of experience across key financial services industry verticals, brings broad leadership capabilities to Tevogen Bio.
  • Most recently, Mr. Shah was Director, Relationship Management, in Citigroup’s Client organization, where he was also a member of the Executive Office.
  • Prior to Citigroup, he worked in Morgan Stanley’s asset management business (MSIM) focused on Equity Strategy and Product Development.

Uber Freight Bolsters Executive Team with Industry Veterans Dan Annunziata and Hany Elkordy to Drive Market Expansion

Retrieved on: 
Wednesday, April 3, 2024
Last mile, Convoy, Truckload shipping, Growth, Amazon, Transport, LTL, Business, Magic, Small business, Commercial, Head, Intermodal transport, Heart, 3PL, Last, Amazon (company), Norfolk Southern Railway

Joining the Uber Freight family Dan Annunziata, appointed as Head of Commercial, and Hany Elkordy, assuming leadership of the Last Mile division.

Key Points: 
  • Joining the Uber Freight family Dan Annunziata, appointed as Head of Commercial, and Hany Elkordy, assuming leadership of the Last Mile division.
  • “Uber Freight has a compelling value proposition for shippers of all types; long gone are the days of the perceived digital startup,” said Dan Annunziata.
  • In his new role at Uber Freight, Hany will spearhead parcel modality enhancements and expansion, working closely with product, operations, and technology teams.
  • “Uber Freight is uniquely positioned to expand its logistics solutions into the Final Mile space,” said Hany Elkordy.

Rogers $1M Season of Canada’s Got Talent: Top Performances from Tonight’s Episode on Citytv

Retrieved on: 
Wednesday, April 3, 2024
QC, CIBC, Head, BALL, HEAD, Toronto Maple Leafs, Magic, Glass, Wine, CGT, Lilly, AIR, TROY, Singing, MICHAEL

DANIEL POWTER (Vernon, BC) surprised the audience by singing “Bad Day,” an original song he wrote that topped the charts for several weeks in 2005.

Key Points: 
  • DANIEL POWTER (Vernon, BC) surprised the audience by singing “Bad Day,” an original song he wrote that topped the charts for several weeks in 2005.
  • MITCHELL HRYCAN (Saskatoon, SK) duped the judges when his twin, MICHAEL HRYCAN, surprised the crowd in a shocking twist!
  • Together with Canada’s Got Talent, Rogers is committed to investing in premium original Canadian content while fostering homegrown talent.
  • Last year, Rogers contributed approximately $950M to Canadian content and produced over 12,700 hours of unique Canadian programming.

Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC

Retrieved on: 
Wednesday, April 3, 2024
University of London, University, Public health, Growth, Health, Patient, Business development, Columbia University, Head, L.E.K. Consulting, MBA, Medtech, Master, MPH, Partner, SOAS

Tokyo, Japan and Cambridge, UK, 3 April 2024 - Nxera Pharma (“Nxera” or “the Company”; TSE: 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region.

Key Points: 
  • Tokyo, Japan and Cambridge, UK, 3 April 2024 - Nxera Pharma (“Nxera” or “the Company”; TSE: 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region.
  • Branch will join Nxera’s global Business Development team that is led by Dr. Marcus Messenger.
  • He will be based in Nxera’s Tokyo office and will oversee Japan and regional disease area strategy, search and evaluation, and transaction activities.
  • Chris Cargill, CEO and President of Nxera Pharma, commented: “I’m delighted to welcome Patrick to the business development team at Nxera.

MissionSquare Retirement Announces Retirement of Chief Investment Officer Wayne Wicker Following Distinguished Financial Services Career

Retrieved on: 
Tuesday, April 2, 2024
CIO, Health, Retirement, ESG, University, Head, Wicker, MBA, Washington State University, Investment, CFA, CAIA, National university, Financial adviser

Washington D.C., April 02, 2024 (GLOBE NEWSWIRE) -- MissionSquare Retirement , a staunch advocate of retirement security and financial well-being, today announces the retirement of Wayne Wicker, the company’s highly respected Chief Investment Officer (CIO).

Key Points: 
  • Washington D.C., April 02, 2024 (GLOBE NEWSWIRE) -- MissionSquare Retirement , a staunch advocate of retirement security and financial well-being, today announces the retirement of Wayne Wicker, the company’s highly respected Chief Investment Officer (CIO).
  • Karen Chong-Wulff , CFA, CAIA, Head of Fixed Income for MissionSquare Retirement, will succeed Wicker as Acting CIO, effective April 5, 2024, in accordance with the company’s succession plan.
  • “MissionSquare Retirement is grateful for Wayne’s twenty years of service to the company, and we wish him the very best in his well-deserved retirement,” said Deanna J. Santana, Acting CEO & President at MissionSquare Retirement.
  • Prior to joining MissionSquare Retirement in July 2007, Chong-Wulff held senior positions at DuPont Capital Management and Morley Capital Management.

Greenbacker grows investments team to continue push into Energy Transition Real Estate, hires new Head of Acquisitions

Retrieved on: 
Tuesday, April 2, 2024
EV, Assistant, Head, Investment, Renewable energy

“Real estate with access to power and grid infrastructure is mission critical to the energy transition.

Key Points: 
  • “Real estate with access to power and grid infrastructure is mission critical to the energy transition.
  • Evan shares our belief that decarbonization and the resulting ‘electrification of everything’ will create massive investment opportunities in Energy Transition Real Estate.
  • “The company’s collective business intelligence, renewable power expertise, and access to proprietary deal flow positions Greenbacker to drive the energy transition within the trillion-dollar real estate industry.
  • I’m excited to rejoin David as we continue to expand Greenbacker’s platform into the Energy Transition Real Estate space.”
    GCM’s real estate investments team has also added a new Assistant Vice President of Acquisitions, Mandy Yang, responsible for originating, underwriting, and executing real estate opportunities that align with the strategy’s goals.

Endexx Corporation's HYLA Accelerates Global Reach in Vape Innovation With Strategic Distribution Milestones

Retrieved on: 
Tuesday, April 2, 2024
Partnership, HYLA, Head, Confidentiality, Growth, CAVE, OTC, Sale, Airline

Endexx Corporation, transitioning to HYLA, has finalized a substantial sale amounting to $348,812.50 with a premier distributor in Houston, Texas.

Key Points: 
  • Endexx Corporation, transitioning to HYLA, has finalized a substantial sale amounting to $348,812.50 with a premier distributor in Houston, Texas.
  • This trajectory is set to catapult HYLA towards realizing multimillion-dollar revenues as we witness accelerated market adoption and sales momentum.
  • The transformation from Endexx Corporation to HYLA symbolizes our unwavering dedication to innovation, environmental stewardship, and enhancing wellness.
  • This inaugural distribution agreement is a testament to our vision of becoming the premier choice for lifestyle and wellness products.

Sompo announces leadership changes for Asia Pacific Region

Retrieved on: 
Tuesday, April 2, 2024
Growth, Head, Management

PEMBROKE, Bermuda, April 02, 2024 (GLOBE NEWSWIRE) -- Sompo, a leading global provider of commercial and consumer property and casualty (re)insurance, today announced leadership changes to support the further growth of its insurance business in the Asia Pacific region.

Key Points: 
  • Kenneth Reilly appointed as Chief Executive Officer, Insurance, Asia Pacific
    PEMBROKE, Bermuda, April 02, 2024 (GLOBE NEWSWIRE) -- Sompo, a leading global provider of commercial and consumer property and casualty (re)insurance, today announced leadership changes to support the further growth of its insurance business in the Asia Pacific region.
  • Kenneth Reilly is appointed as Chief Executive Officer (CEO), Insurance, for the Asia Pacific region, subject to appropriate regulatory and immigration approvals.
  • In his new role, Mr. Reilly will be responsible for all of Sompo’s insurance business across Asia Pacific.
  • Having been a pivotal leader in our Tokyo office for almost two years, Ken has demonstrated a commitment to promoting best practices and reinforcing strategic alignment between Sompo and the other Sompo Group insurance companies.”
    Sompo would also like to thank Daniel for his contribution to Sompo and the Asia Pacific region where he has held several leadership roles.

Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update

Retrieved on: 
Tuesday, April 2, 2024
Skin care, Research, Lung cancer, Ovarian cancer, DP, Head, Conference, Face, Cell, Skin cancer, Immunotherapy, TIL, Clinical, Cancer, Cervical cancer, HNSCC, George Washington University, Patient, Gene, American Academy, D&O, IND, Centricity, AACR, Glioblastoma, Skin, Breast cancer, Scalp, Melanoma, Patent, SITC, Private law, FDA, BRD4, Food, Pharmaceutical industry

MARLBOROUGH, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today reported its financial results for the year ended December 31, 2023 and provided a business update.

Key Points: 
  • The latter clearance was significant since there are no drugs specifically approved to treat early stages I and II of cSCC.
  • As of February, the first two patients in our first cohort have completed treatment with PH-762 with no reported adverse events.
  • In 2023 we implemented a cost rationalization program driven by our transition from discovery research to product development.
  • At December 31, 2023 we had cash of $8.5 million as compared with $11.8 million at December 31, 2022.